SCHEMBL741044

SCHEMBL741044

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccsc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.51
ABL1 P00519 2/20 0.49
BCR P11274 2/20 0.49
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HPGD P15428 1/20 0.40
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
SGK1 O00141 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
CDK7 P50613 2/20 0.37
IMPDH2 P12268 1/20 0.36
GRM5 P41594 1/20 0.36
USP36 Q9P275 1/20 0.35
TACR3 P29371 1/20 0.35
EGLN1 Q9GZT9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778872 0.94 AURKA (0.46) AURKAABL1BCRNPC1RAB9A
SCHEMBL740292 0.90 AURKA (0.55) AURKAABL1BCRNPC1RAB9A
SCHEMBL740809 0.87 AURKA (0.52) AURKAABL1BCRKCNK3CDK7
SCHEMBL738866 0.86 AURKA (0.53) AURKAABL1BCRNPC1RAB9A
SCHEMBL741311 0.86 AURKA (0.53) AURKAABL1BCRNPC1RAB9A
SCHEMBL743308 0.85 AURKA (0.48) AURKAABL1BCRNPC1RAB9A
SCHEMBL742071 0.85 AURKA (0.46) AURKAABL1BCRNPC1RAB9A
SCHEMBL740955 0.84 CDK7 (0.48) AURKAABL1BCRKCNK3CDK7
SCHEMBL1779700 0.84 AURKA (0.50) AURKAABL1BCRNPC1RAB9A
SCHEMBL739779 0.84 AURKA (0.52) AURKAABL1BCRNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed